Clinical Trials Browser

Phase 2/3 × Carcinoma, Transitional Cell × pembrolizumab × Clear all

NCT06493552 2025-04-03

Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors

Phase 2/3 Recruiting

Carcinoma, Transitional Cell